Table 3.
Patient characteristics according to PHLF grade.
| Variables | Non-PHLF (n = 48) | PHLF Grade A (n = 43) | PHLF Grade B (n = 16) | P value |
|---|---|---|---|---|
| Age, years | 69 (38–82) | 68 (40–86) | 69 (56–93) | 0.59 |
| Sex, male, % | 75.0 | 55.8 | 75 | 0.12 |
| HBs antigen+, % | 14.5 | 11.6 | 6.3 | 0.68 |
| HCV antibody+, % | 10.4 | 11.6 | 31.3 | 0.10 |
| ICGK | 0.154 (0.069–0.212) | 0.156 (0.091–0.264) | 0.137 (0.085–0.211) | 0.21 |
| ICGR15, % | 9.9 (4.2–35.4) | 10.2 (1.9–25.6) | 12.9 (4.2–27.8) | 0.39 |
| TLV, mL | 1214 (786–2025) | 1133 (735–2086) | 1320 (829–2169) | 0.39 |
| % RLV | 68.9 (40.5–93.7) | 55.9 (34.7–87.0) | 44.0 (37.2–80.2) | <0.001 |
| rICGK | 0.095 (0.053–0.199) | 0.079 (0.050–0.153) | 0.067 (0.050–0.088) | <0.001 |
| T-Bil, mg/dL | 0.5 (0.2–2.5) | 0.7 (0.3–1.9) | 0.7 (0.4–2.2) | 0.74 |
| Alb, g/dL | 4.1 (1.8–5.2) | 4.1 (2.6–4.7) | 3.9 (3.0–4.7) | 0.31 |
| Plt, 104/μL | 19.4 (8.3–72.0) | 17.0 (9.7–41.5) | 17.7 (8.6–45.5) | 0.68 |
| PT-INR | 1.03 (0.93–1.93) | 1.03 (0.94–1.35) | 1.06 (0.94–1.31) | 0.93 |
| eGFR (mL/min) | 75.8 (53.2–124.4) | 74.1 (6.5–186.0) | 69.3 (38.9–120.4) | 0.54 |
| Blood loss, mL | 440 (50–2600) | 500 (70–7750) | 1385 (230–3400) | 0.047 |
| Operation time, min | 328 (151–654) | 348 (204–620) | 401 (286–748) | 0.02 |
P values between the three groups were assessed by one-way analysis of variance and the Tukey multiple comparison procedure.